Articles

Found results: 16309

Biotechnologies - into life

Russian biopharmaceuticals: until the thunder breaks…

Academician Anatoly Miroshnikov: "Russia, apparently, needs a big trouble to understand how important it is to have its own pharmaceutical industry with a full cycle of creating at least vital drugs."

22.06.2009
Cloning

Clone a mammoth? Unreal!

The successes of recent years in deciphering the genetic code of mammoths have given rise to expectations in society of the imminent "return" of these ancient animals. Nikolai Yankovsky says that these expectations have little to do with reality.

22.06.2009
Genetics

The Congress of Geneticists and Breeders begins

The largest forum of Russian geneticists is the Congress of Geneticists and Breeders dedicated to the 200th anniversary of the birth of Charles Darwin, and the 5th Congress of the Vavilov Society of Geneticists and Breeders opens on June 22.

22.06.2009
Healthy skepticism

The saga of dietary supplements

What are dietary supplements? Can they, as their sellers claim, cure many diseases? Or maybe all dietary supplements (or most of them) are useless and even dangerous? Let's figure it out.

22.06.2009
Bioethics

I'll sell a kidney. Expensive

The surgeon Dmitry Granov considers stories about abductions of people "for organs" and clandestine clinics to be horror stories, behind which there is nothing but the sick fantasy of their authors. The well-known criminologist Yakov Gilinsky believes that it is impossible to exclude the possibility of committing such crimes in Russia. The demand for donor organs is huge, and the prices are too high for criminal structures to bypass this topic.

19.06.2009
Exhibitions and conferences

What is happening in the pharmaceutical market?

International Conference "What is happening in the pharmaceutical market? Autumn session of Farm Leaders" (September 21-22, 2009, Moscow, Marriott Aurora Hotel).

19.06.2009
Healthy skepticism

Prayers for health do not cure

American sociologist Wendy Cage has denied the connection between the power of prayers and the condition of patients. She concluded that such studies could not find a reliable effect.

19.06.2009
Prolonging youth

Anti-aging Science: v.2.0

We propose for discussion, correction and addition one of the approaches to the preparation of the program "Science against Aging", proposed by Russian scientists.

19.06.2009
Genetics

The interchangeability of regulatory genes protects against diseases

There are much more similarities between genes and computer networks than previously thought. In both cases, the key elements of the systems are duplicated. This discovery will allow us to find vulnerable genes responsible for the development of diseases.

18.06.2009
Note to the businessman

There is no national science, just as there is no national multiplication table

Science has ceased to be national, says Dr. Ruth David, a member of the Presidential National Security Council of the United States, president of the independent non-profit research institute ANSER. According to her, the trend towards the globalization of science will lead to a gradual shift of research to developing countries.

18.06.2009
Biomedicine

Bionanotechnology in the interests of man

The Institute of Chemical Biology and Fundamental Medicine SB RAS held a conference "Chemical Biology – Fundamental problems of Bionanotechnology" on June 10-14.

18.06.2009
Biomedicine

Biopharmaceuticals: originals and analogues

Analogues of biopharmaceutical drugs are called biosimilars or bioengineers, in the USA they are called modified biopharmaceuticals. Reproduced biopharmaceuticals are also called "biosimilars" ("biosimilars"), and this term has been used most frequently in recent years.

18.06.2009
Controversial

Cyborgs are among us

While genetic engineers are looking for arguments in a dispute with the authorities about cloning, ordinary engineers have already begun to turn humanity into cyborgs.

17.06.2009
New in Gerontology

The key target of the aging regulator has been discovered

Sirtuins at the cellular level maintain the integrity of the genome, increase resistance to adverse factors and resist physiological aging. Scientists from the Wistar Institute for the first time demonstrated the molecular target of one of the representatives of this class of proteins, Sir2, in the process of regulating the aging of yeast cells.

17.06.2009
Note to the businessman

Russian Pharmaceutical Forum 2009: the strongest survives the crisis

Hundreds of participants, not only from different parts of Russia, but also from all over the world, came to the Adam Smith Institute conference "Russian Pharmaceutical Forum" to try to figure out for themselves how Russian pharma will develop in the era of the global economic crisis.

16.06.2009
Genetics

Genes of schizophrenia and depression: the answer is close

Comparison of isolated populations with frequent occurrence of the same disease makes it possible to determine the entire spectrum of genes associated with it. This approach allowed us to establish a number of important facts in the identification of schizophrenia and depression genes.

16.06.2009
New in Gerontology

The most complete database on life expectancy

Unlike many other resources of this kind, the AnAge database includes only scientifically confirmed data. The database contains information about the maximum life expectancy of 3,650 vertebrate species (humans are in 11th place among them), as well as body weight, growth and puberty rates, reproduction rate and other characteristics that can be used for comparative studies.

16.06.2009
Genetics

All the genes of all diseases in one database

The project of scientists from Olga Troyanskaya's group at Princeton University has become part of the revolution in medical and biological science that has been taking place in recent years. Data on the function of genes and their activity in various diseases are now collected in one place, and everyone can get acquainted with them.

16.06.2009
Biotechnologies - into life

The path of the innovator: Moscow – Harvard – Boston

He was the youngest professor at Moscow State University, winner of the Lenin Komsomol Prize and winner of the USSR State Prize. He now lives in Boston. Anatoly Klesov has passed the classic path of an innovator, about which a lot of textbooks are written. And now he is a shareholder of an enterprise that uses his developments in the field of composite materials and vice president of a biotech company developing anti-cancer drugs.

15.06.2009